Sera Prognostics (SERA) Other Non-Current Assets (2020 - 2026)
Sera Prognostics (SERA) reported Other Non-Current Assets of $2.5 million for Q1 2026, up 321.09% on a YoY basis from $588000.0 in Q1 2025, and down 1.94% quarter-over-quarter from $2.5 million in Q4 2025.
Sera Prognostics (SERA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Sera Prognostics has reported Other Non-Current Assets for 7 years, with the latest figure at $2.5 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 321.09% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 321.09% YoY), and the FY2025 full-year result was $2.5 million, up 242.61% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $2.5 million, down from $2.5 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $2.6 million in Q3 2025, with the low at $237000.0 in Q3 2022.
- Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $1.5 million in 2023.
- The largest YoY upside for Other Non-Current Assets was 1056.69% in 2022 against a maximum downside of 87.16% in 2022.
- Sera Prognostics' Other Non-Current Assets stood at $1.8 million in 2022, then tumbled by 30.78% to $1.3 million in 2023, then slumped by 41.37% to $737000.0 in 2024, then jumped by 242.61% to $2.5 million in 2025, then retreated by 1.94% to $2.5 million in 2026.
- The last three Other Non-Current Assets figures came in at $2.5 million (Q1 2026), $2.5 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Sera Prognostics | 93.48 Mn | 93.48 Mn | -28,000.00 | 2.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.48 Mn |
| Dec 31, 2025 | 2.53 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 435,000.00 |
| Mar 31, 2025 | 588,000.00 |
| Dec 31, 2024 | 737,000.00 |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 1.82 Mn |
| Sep 30, 2022 | 237,000.00 |
| Jun 30, 2022 | 363,000.00 |
| Mar 31, 2022 | 487,000.00 |
| Dec 31, 2021 | 157,000.00 |
| Sep 30, 2021 | 168,000.00 |
| Jun 30, 2021 | 2.83 Mn |